Thus, neutrophils can adopt the N1 phenotype, which supports anti-tumor immunity by counteracting transforming growth factor-β (TGF-β) signaling [131] or, under the influence of TGF-β, neutrophils may switch into the N2 phenotype, which is characterized by immunosuppressive abilities that facilitate tumor progression [131]. Here, TGFB1 is linked to neoplasm.